Advancing Cancer Treatment Through Research & Innovation
Our research focuses on developing breakthrough treatments that combine cutting-edge science with personalized patient care, pushing the boundaries of what's possible in cancer treatment.
Current Research Projects
Our current research projects are focused on developing breakthrough treatments that combine cutting-edge science with personalized patient care, pushing the boundaries of what's possible in cancer treatment.
Efficacy of Compression Therapy for Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients with Early Breast Cancer: Insights from a Single-Centre Experience in Bangladesh
Prospective
Research Objectives:
- • Incidence of CTCAE version 5 grade 2 or higher CIPN in both upper and lower extremities during entire period of chemotherapy.
The Efficacy of Pembrolizumab for Treatment of Early Triple Negative Breast Cancer: A Single-center, Open, Randomized Controlled Trial
Primary endpoints: A) Pathological Complete Response at the time of definitive surgery B) Event-free survival in the intention-to-treat population Secondary endpoints: Overall survival at the end of 15 months
Research Objectives:
- • A prospective study to measure the efficacy of Pembrolizumab in Early Triple Negative Breast Cancer (TNBC) patients of Bangladeshi population.
Recent Publications
Peer-reviewed research contributions published in leading oncology journals, advancing the field of cancer treatment.
Tracheal Adenocarcinoma Treated with Adjuvant Radiation: A Case Report and Literature Review
Primary adenocarcinoma of the trachea is extremely rare and a standard treatment does not exist due to nonavailability of evidence-based randomized control studies. This paper reports the case of a …
Key Findings:
Our 60-year-old diabetic and hypertensive male patient had a 1-month history of cough associated with marked respiratory distress and occasional dyspnea in the right lateral …
Showing 19 to 19 of 19 publications
Conference Presentations & Speaking Engagements
Sharing research findings and clinical insights at leading medical conferences worldwide.
ESMO Asia 2025
Clinicopathological pathological characteristics in young breast cancer patient
A single center retrospectives study in a low and middle income country
KSMO 2025
Survival Analysis of CNS patients in Bangladesh – focusing the multidisciplinary approaches among 149 patients in a single centre retrospective analysis from 2018- 2023.
Introduction: Central Nervous Tumor (CNS) tumor is variable survival status due to its location and age groups. We tried to find selected CNS tumors among adult and child with tri-modalities treatment and compared the survival and prognostic factors among 149 patients first time in Bangladesh. Methods: Retrospective analysis was done through hospital information system among CNS tumors patient’s prescription from 2018 to 2023. Follow up was also confirmed through tele conversation where the last follow up was not recent. A model with python created to analyze the survival in different groups with log rank test and COX proportional hazard ratio also tested.
Showing 5 to 6 of 6 presentations